Schedule 13G ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Common Stock, par value $0.0001 per share · CUSIP: 76152G100

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 3,910,304.00 · Class: 7.80%

  • KEVIN TANG

    Shares: 3,910,304.00 · Class: 7.80%

  • TANG CAPITAL PARTNERS, LP

    Shares: 3,656,983.00 · Class: 7.29%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 223,321.00 · Class: 0.45%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 24,000.00 · Class: 0.05%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 6,000.00 · Class: 0.01%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-007880
Form type
SCHEDULE 13G/A
Filer
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK
CIK 1742927
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub